Accelerate Diagnostics Inc PEG
Quel est le PEG de Accelerate Diagnostics Inc?
Le PEG de Accelerate Diagnostics Inc est N/A
Quelle est la définition de PEG ?
Le ratio cours / bénéfice sur croissance (PEG) est le ratio P/E d'une action divisé par le taux de croissance de ses bénéfices prévu pour une période de 5 ans.
The PEG ratio is calculated by dividing the P/E ratio by the company's expected earnings growth rate in the next 5 years. Since using just the P/E ratio would make high-growth companies appear overvalued relative to others, the PEG ratio is considered to be a convenient approximation. PEG is a widely employed indicator of a stock's possible true value.
Similar to P/E ratios, a lower PEG means that the stock is undervalued more. It is favored by many over the price/earnings ratio because it also accounts for growth. The PEG ratio of 1 is sometimes said to represent a fair trade-off between the values of cost and the values of growth, indicating that a stock is reasonably valued given the expected growth. A crude analysis suggests that companies with PEG values between 0 and 1 may provide higher returns. A PEG Ratio can also be a negative number if a stock's present income figure is negative, (negative earnings) or if future earnings are expected to drop (negative growth). PEG ratios calculated from negative present earnings are viewed with skepticism as almost meaningless, other than as an indication of high investment risk.
PEG des entreprises dans Health Care secteur sur NASDAQ par rapport à Accelerate Diagnostics Inc
Que fait Accelerate Diagnostics Inc?
accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
Entreprises avec peg similaire à Accelerate Diagnostics Inc
- Leju Ltd a PEG de N/A
- Stuart Olson a PEG de N/A
- Castlight Health Inc a PEG de N/A
- Nava Bharat Ventures a PEG de N/A
- CYREN Ltd a PEG de N/A
- Radius Recycling a PEG de N/A
- Accelerate Diagnostics Inc a PEG de N/A
- Ternium S.A a PEG de N/A
- CBL& Associates Properties a PEG de N/A
- Intellia Therapeutics Inc a PEG de N/A
- Flotek Industries Inc a PEG de N/A
- Beasley Broadcast Inc a PEG de N/A
- Kosmos a PEG de N/A